Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this free, full length talk
Topics Covered
- Monitoring the levels of immune cells, e.g. memory B cells, rather than levels of antibodies, as an indication of long term immune protection
- The efficacy of vaccines in previously infected vs previously uninfected individuals
- The efficacy of a single vs double dose
- The potential value of administrating a ‘booster’ that is different from the previous administered vaccine in an individual, AKA “mixing-and-matching”
Biography
Dr. E. John Wherry is the Barbara and Richard Schiffrin President’s Distinguished Professor, Chair of the Department of Systems Pharmacology and Translational Therapeutics in the Perelman School of Medicine, and Director of the University of Pennsylvania Institute for Immunology. He has received numerous honors including the Distinguished Alumni award from the Thomas Jefferson University and the Cancer Research Institute’s Frederick W. Alt Award for New Discoveries in Immunology. Dr. Wherry has over 260 publications, which have been cited over 67,000 times.
Dr. Wherry helped pioneering the field of T cell exhaustion, the mechanism by which T cell responses are attenuated during chronic infections and cancer. He also helped identify the role of the “checkpoint” molecule PD-1 and others for reinvigoration of exhausted T cells in cancer. His laboratory has recently focused on applying Systems Immunology approaches to define Immune Health patients across a spectrum of diseases. In 2020-2021, Dr. Wherry’s laboratory focused considerable efforts on the immunology of COVID-19 and SARS-CoV-2 vaccination including establishing a new Immune Health Project to interrogate and use immune features to identify novel treatment opportunities.
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Wherry, E.J. (2021, August 2). mRNA COVID-19 vaccine efficacy in recovered vs COVID-naive individuals [Audio file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 23, 2024, from https://doi.org/10.69645/MSMC4694.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. E. John Wherry has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Other Talks in the Playlist: Interviews on Covid-19
Transcript
Quiz
Disclaimer: This quiz is intended for learning assessment purposes only and does not grant any certification or credit.
If you are interested in getting a certificate for watching the talk, follow the instructions in this talk's Accreditation Information (where available.)